Flow Space on MSN
Update: FDA approves oral version of Wegovy, first GLP-1 pill approved specifically for weight management
Just before the end of 2025, an oral version of a GLP-1 drug specifically used for weight management moved much closer to ...
From immune cell therapies to measles outbreaks to federal attacks on public health, these are some of the health topics ...
MarketBeat on MSN
Eli Lilly's new drug data sets up a high-stakes 2026
Since early August, the world’s most valuable pharmaceutical stock, Eli Lilly and Company (NYSE: LLY), has put on a stellar ...
U.S. regulators this week gave the green light to a pill version of the blockbuster weight-loss drug Wegovy, the first daily oral medication to treat obesity.
Philadelphia has filed a lawsuit against several major drug manufacturers and pharmacy benefit managers, accusing them of ...
U.S. President Donald Trump, Eli Lilly (LLY.N) and Novo Nordisk (NOVOb.CO) signed a deal in November to slash the prices of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback